Needham Maintains Buy on Cardlytics, Raises Price Target to $19
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Kyle Peterson maintains a Buy rating on Cardlytics (NASDAQ:CDLX) and raises the price target from $10 to $19.

August 04, 2023 | 10:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst maintains a Buy rating on Cardlytics and raises the price target from $10 to $19.
The news of Needham maintaining a Buy rating and raising the price target for Cardlytics is likely to have a positive impact on the stock. This is because it signals confidence in the company's future performance, which can attract more investors and potentially drive up the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100